PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-15.68%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.11B
AUM Growth
+$1.11B
(-14%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
11.5%
Top 10 Holdings %
Top 10 Hldgs %
47.87%
Holding
199
New
48
Increased
49
Reduced
18
Closed
34
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$31.1M |
| 2 |
Humana
HUM
|
$20.1M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.6M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$13.9M |
| 5 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$12.1M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$68.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$11.8M |
| 3 |
Baxter International
BAX
|
$10.9M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$8.54M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$7.63M |
Sector Composition
| 1 | Healthcare | 92.2% |
| 2 | Consumer Discretionary | 0.11% |
| 3 | Industrials | 0.05% |
| 4 | Financials | 0.02% |
| 5 | Consumer Staples | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $129M | 11.29% | 15,239,444 | – | – |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $108M | 9.44% | 2,720,967 +224,800 | +9% | +$8.89M |
|
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $74.8M | 6.56% | 3,833,128 +1,592,200 | +71% | +$31.1M |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $48.4M | 4.24% | 1,098,659 +130,000 | +13% | +$5.72M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $41.5M | 3.64% | 155,000 +10,000 | +7% | +$2.68M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $41M | 3.59% | 2,999,380 +420,000 | +16% | +$5.74M |
|
7
Xencor
XNCR
$580M
| $24.2M | 2.12% | 1,804,784 -50,000 | -3% | -$671K |
|
|
ARAV
8
DELISTED
Aravive, Inc. Common Stock
ARAV
| $22.7M | 1.99% | 2,835,754 +536,300 | +23% | +$4.3M |
|
|
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
| $21.2M | 1.86% | 803,036 +527,000 | +191% | +$13.9M |
|
|
GBT
10
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $20.6M | 1.8% | 1,297,468 +110,838 | +9% | +$1.76M |
|
|
11
Humana
HUM
$36.5B
| $20.1M | 1.77% | +110,000 | New | +$20.1M |
|
|
NVRO
12
DELISTED
NEVRO CORP.
NVRO
| $19.6M | 1.72% | 348,600 -135,679 | -28% | -$7.63M |
|
|
QTNT
13
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $19.1M | 1.68% | 2,189,067 +1,295,527 | +145% | +$11.3M |
|
14
Talphera
TLPH
$11.1M
| $18.5M | 1.62% | 5,995,760 | – | – |
|
|
FPRX
15
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $18.5M | 1.62% | 454,129 +20,000 | +5% | +$813K |
|
16
uniQure
QURE
$896M
| $17.1M | 1.5% | 1,442,093 +475,000 | +49% | +$5.64M |
|
|
MDVN
17
DELISTED
MEDIVATION, INC.
MDVN
| $15.6M | 1.37% | +340,000 | New | +$15.6M |
|
|
LJPC
18
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $14.6M | 1.28% | 699,515 +50,000 | +8% | +$1.05M |
|
19
Iovance Biotherapeutics
IOVA
$807M
| $14.2M | 1.24% | 2,787,256 -212,905 | -7% | -$1.08M |
|
|
20
Teva Pharmaceuticals
TEVA
$21.1B
| $14M | 1.23% | 261,000 -220,000 | -46% | -$11.8M |
|
|
DBVT
21
DBV Technologies
DBVT
$264M
| $13.6M | 1.19% | 416,696 +109,981 | +36% | +$3.58M |
|
22
Vertex Pharmaceuticals
VRTX
$100B
| $12.7M | 1.12% | 160,000 +50,000 | +45% | +$3.97M |
|
|
CPXX
23
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $12.1M | 1.06% | +1,100,000 | New | +$12.1M |
|
|
DERM
24
DELISTED
Dermira, Inc.
DERM
| $10.6M | 0.93% | 512,000 +10,000 | +2% | +$207K |
|
25
Sonida Senior Living
SNDA
$488M
| $10.1M | 0.88% | 544,636 +60,936 | +13% | +$1.13M |
|